Serum concentrations of CA-125 in normal and preeclamptic pregnancies

Archives of Gynecology and Obstetrics

Volumn 284, Issue 3, 2011, Pages 607-612

  Ozat, Mustafa ^a   Kanat Pektas, Mine ^b   Yenicesu, Okan ^a   Gungor, Tayfun ^a   Danisman, Nuri ^a   Mollamahmutoglu, Leyla ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Etlik Ihtisas Research and Education Hospital   (Turkey)

Author keywords

CA 125; Concentration; Preeclampsia; Pregnancy

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; URIC ACID;

ADULT; ARTICLE; BIRTH WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FETUS WEIGHT; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREECLAMPSIA; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; URIC ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; HOSPITALIZATION; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PROTEINURIA; REFERENCE VALUE; URINE;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIRTH WEIGHT; BLOOD PRESSURE; CA-125 ANTIGEN; FEMALE; FETAL WEIGHT; HUMANS; PLATELET COUNT; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROSPECTIVE STUDIES; PROTEINURIA; REFERENCE VALUES; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; URIC ACID; YOUNG ADULT;

EID: 84855987870     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1736-2     Document Type: Article

References (19)

1. Lindheimer MD, Taler SJ, Cunningham FG (2010) Hypertension in pregnancy. J Am Soc Hypertens 4(2):68-78
2. Deruelle P, Girard JM, Coutty N, Subtil D (2010) Prevention of preeclampsia. Ann Fr Anesth Reanim 29(3): e31-e35
3. Gadducci A, Cosio S, Carpi A, Nicolini A, Genazzini AR (2004) Serum tumor markers in management of ovarian, endometrial and cervical cancer. Biomed Pharmacother 58:24-38 (Pubitemid 38117046)
4. Predanic M (2000) Differentiating tubal abortion from viable ectopic pregnancy with serum CA-125 and beta-human chorionic gonadotropin determinations. Fertil Steril 73:522-525 (Pubitemid 30109648)
5. Hsieh CH, Chang Chien CC, Lin H, Huang EY, Huang CC, Lan KC (2002) Can a pre-operative CA-125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86:28-33 (Pubitemid 34757047)
6. Santala M, Talvensaari-Mattila A, Kauppila A (2003) Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Res 23(3 C):3097-3103 (Pubitemid 36969868)
7. Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH (2005) Preoperative serum CA-125 levels in treating endometrial cancer. J Reprod Med 50:585-590 (Pubitemid 41193137)
8. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2006) Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 85(12):1501-1505
9. Fiegler P, Kaminski K, Wegrzyn P (2003) Serum CA125 variability-new aspects of clinical usefulness. Ginekol Pol 74(5):412-418
10. Malatyalioglu E, Ozer S, Kokcu A, Cetinkaya MB, Alper T (2006) CA-125 levels in ruptured and unruptured tubal ectopic pregnancies. J Obstet Gynaecol Res 32(4):422-427 (Pubitemid 44050741)
11. Katsikis I, Rousso D, Farmakiotis D, Kourtis A, Diamanti-Kandarakis E (2006) Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestations. Eur J Obstet Gynecol Reprod Biol 125(2):226-232
12. Schmidt T, Rein DT, Foth D (2001) Prognostic value of repeated serum CA 125 measurements in first trimester pregnancy. Eur J Obstet Gynecol Reprod Biol 97:168-173 (Pubitemid 32651683)
13. Schröcksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O (1993) Tumor markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest 35(4):204-208 (Pubitemid 23174507)
14. de Groot CJ, O'Brien TJ, Taylor RN (1996) Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J Obstet Gynecol 175(1):24-29 (Pubitemid 26282201)
15. Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ, van Geijn HP, van Vugt JM (2001) Maternal serum CA-125 and CA 15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther 16(3):166-172 (Pubitemid 32337207)
16. Cebesoy FB, Balat O, Dikensoy E, Kalayci H, Ibar Y (2009) CA-125 and CRP are elevated in preeclampsia. Hypertens Pregnancy 28(2):201-211
17. National High Blood Pressure Education Program Working Group (2000) Report on high blood pressure in pregnancy. National Institutes of Health Publication No. 00-3029. National Institutes of Health, Washington, DC
18. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H (2010) An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202(2):161.e1-161.e11
19. Hirashima C, Ohkuchi A, Arai F, Takahashi K, Suzuki H, Watanabe T, Kario K, Matsubara S, Suzuki M (2005) Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res 28(9):727-732 (Pubitemid 41723531)